Fosun Group appears to be back in a shopping mood as its founder Guo Guangchang makes a high profile public appearance on China's central television station. Yesterday, Shanghai Fosun Pharmaceutical (Group) Co. made a non-binding proposal to acquire KKR-backed Gland Pharma in India for up to US$1.5 billion, in the first major move after Guo […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.